What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Regulatory policies related to the health reform law: structure, drug benefits, disclosure. Regulatory implementation of HITECH/accounting of disclosures. Issues regarding making prescription drugs more affordable. Restrictions on specialty tiering.
Contacted: Labor, Dept of (DOL); Government Accountability Office (GAO); Congressional Budget Office (CBO); SENATE; HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Office of Personnel Management (OPM); Health Resources & Services Administration (HRSA); Federal Trade Commission (FTC); Executive Office of the President (EOP); White House Office; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC)
Legislation to exempt certain pharmacies from the antitrust laws for the purposes of negotiating with payers (HR XXXX).
Contacted: Executive Office of the President (EOP); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); White House Office; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Labor, Dept of (DOL); SENATE; Health Resources & Services Administration (HRSA); Internal Revenue Service (IRS); Congressional Budget Office (CBO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Office of Personnel Management (OPM)
Postal reform proposals and their impact on 6 day mail delivery.
Contacted: Food & Drug Administration (FDA); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); Government Accountability Office (GAO); SENATE; Congressional Budget Office (CBO); Labor, Dept of (DOL); White House Office
Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General Legislative and regulatory issues such as direct negotiation. Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors prompt pay discounts from the definition of average sales prices. Medicare audit and preferred network restrictions. HR 244; HR 793.
Contacted: Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO); White House Office; Government Accountability Office (GAO); SENATE; Labor, Dept of (DOL); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS)
Bills named:
H.R. 244 (114th), H.R. 793 (114th)
Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR, specialty pharmacy tiering restrictions. Regulatory implementation of a pathway for the approval of biosimilars. REMs. 340b program reform. policies placing restrictions on pharmacy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse, including Medicare lock-in programs. General issues dealing with regulating pharmacy drug compounding. HR 1600.
Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Internal Revenue Service (IRS); SENATE; Federal Trade Commission (FTC); Government Accountability Office (GAO); White House Office; Health Resources & Services Administration (HRSA)
Bills named:
H.R. 1600 (114th)
Regulatory implementation of various tax provisions in the health reform law.
Contacted: HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); SENATE; White House Office; Congressional Budget Office (CBO); Federal Trade Commission (FTC); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Executive Office of the President (EOP); Labor, Dept of (DOL); Internal Revenue Service (IRS); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)
Pharmacy issues related to the 2015 annual defense reauthorization (113th Congress - HR 4438)
Contacted: Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Congressional Budget Office (CBO); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Personnel Management (OPM); SENATE; Internal Revenue Service (IRS); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); White House Office
Bills named:
H.R. 4438 (114th)
Shown as published by the Senate Office of Public Records and the House Clerk under the
Lobbying Disclosure Act. The official filing is the record; open it for the full form.